GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for ImmunoGen Stock and on which exchange is it traded?
The symbol for ImmunoGen is IMGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ImmunoGen Stock?
ImmunoGen holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy ImmunoGen Stock?
ImmunoGen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ImmunoGen Stock.

What's the current price of ImmunoGen Stock?
As of the end of day on the 2024-04-18, the price of an ImmunoGen (IMGN) share was $31.23.

What is the 52-week high and low for ImmunoGen Stock?
The 52-week high for ImmunoGen Stock is $31.25 and the 52-week low is $3.99.

What is the market capitalization of ImmunoGen Stock?
As of the 2024-04-18, the market capitalization of ImmunoGen is 8.726B.

When is the next earnings date for ImmunoGen?
The upcoming earnings date for ImmunoGen is Apr 26, 2024.
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT